Literature DB >> 9933683

Retroperitoneal malignant mesenchymoma: imaging findings in five cases.

S Suzuki1, S Furui, T Kokubo, N Moriyama, H Kohtake, K Takeshita, A Harasawa, Y Sasaki, T Yamauchi, T Shirai, S Ban, Y Kikuchi.   

Abstract

BACKGROUND: To describe computed tomographic (CT), magnetic resonance (MR), ultrasonographic (US), and angiographic findings of retroperitoneal malignant mesenchymoma with emphasis on CT findings.
METHODS: Five CT, four US, four angiography, and two MR studies were obtained in five patients with pathologically proven retroperitoneal malignant mesenchymoma.
RESULTS: Tumors were larger than 10 cm (n = 4), well-circumscribed and heterogeneous (n = 4), and with massive intratumorous calcifications (n = 3) on plain CT or US. Tumors showed heterogeneous enhancement on contrast-enhanced CT scans (n = 4) and moderate hypervascularity with heterogeneous staining on angiography (n = 3). Tumors were essentially hypointense on T1-weighted MR images (n = 2) and heterogeneous hyperintense on T2-weighted MR images (n = 2). Plain CT showed a fat-dense structure in a tumor in one patient.
CONCLUSIONS: The radiologic findings of large expansile heterogeneous masses in the retroperitoneum, especially with massive calcifications, were considered to be typical of malignant mesenchymomas.

Entities:  

Mesh:

Year:  1999        PMID: 9933683     DOI: 10.1007/s002619900449

Source DB:  PubMed          Journal:  Abdom Imaging        ISSN: 0942-8925


  2 in total

1.  Retroperitoneal malignant mesenchymoma: a case of mesenchymal mixed tumor with osteosarcoma, leiomyosarcoma, liposarcoma and fibrosarcoma.

Authors:  Jung Eun Choi; Hong Jun Chung; Won Jong Yoo; Myung Hee Chung; Mi Sook Sung; Hae Giu Lee; Il Young Park; Jeana Kim
Journal:  Korean J Radiol       Date:  2002 Oct-Dec       Impact factor: 3.500

2.  Primary malignant mesenchymoma of bladder: Case report and review of the literature.

Authors:  Zecheng Yang; Xiaodong Yang; Xianqi Lu; Lijian Gao; Gang Li; Xuefeng Zhang
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.